Identification of a novel inhibitor of the canonical Wnt pathway.
about
Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsPEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesPigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells.Perivascular macrophage-like melanocyte responsiveness to acoustic trauma--a salient feature of strial barrier associated hearing loss.Interruption of Wnt signaling in Müller cells ameliorates ischemia-induced retinal neovascularization.The Transient Chondrocyte Phenotype in Human Osteophytic Cartilage: A Role of Pigment Epithelium-Derived Factor?Diabetes and retinal vascular dysfunction.Angiogenesis in diabetes and obesityPigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.Development of gene therapy for treatment of age-related macular degeneration.Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia.Revisiting the matricellular concept.Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells.Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1.Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.Pigment Epithelium-Derived Factor (PEDF) Inhibits Wnt/β-catenin Signaling in the LiverWnt signaling in age-related macular degeneration: human macular tissue and mouse model.Pigment Epithelium-Derived Factor (PEDF) mediates cartilage matrix loss in an age-dependent manner under inflammatory conditions.Application of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: In Vitro and in Vivo Study.Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathyInhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.Nitrosative stress plays an important role in Wnt pathway activation in diabetic retinopathyPotential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathymiR-148a is a downstream effector of X-box-binding protein 1 that silences Wnt10b during adipogenesis of 3T3-L1 cells.Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathyThe effects of PEDF on cancer biology: mechanisms of action and therapeutic potentialPigment Epithelium Derived Factor Peptide Protects Murine Hepatocytes from Carbon Tetrachloride-Induced Injury.Pigment epithelium-derived factor (PEDF) prevents retinal cell death via PEDF Receptor (PEDF-R): identification of a functional ligand binding sitePigment epithelium-derived factor (PEDF) normalizes matrix defects in iPSCs derived from Osteogenesis imperfecta Type VI.Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content.Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting Endothelial-to-Mesenchymal Transition in rats with acute myocardial infarction.Pigment epithelium-derived factor alleviates endothelial injury by inhibiting Wnt/β-catenin pathway.PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium.The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Intra-articular Injection of a Substance P Inhibitor Affects Gene Expression in a Joint Contracture Model.MnTBAP Inhibits Bleomycin-Induced Pulmonary Fibrosis by Regulating VEGF and Wnt SignalingPigment Epithelium-derived Factor (PEDF) Blocks Wnt3a Protein-induced Autophagy in Pancreatic Intraepithelial Neoplasms.
P2860
Q27014620-4F7E7359-AD38-4056-A321-1E47568B0A42Q27026916-081C8C4E-0416-48BE-BF17-41A933E87D85Q30393905-A4BE7FFB-EE43-4079-9524-9213586CEA0AQ30431803-620E63DD-660E-4C0E-A8B4-CBE93978FA6FQ34278108-BA3C25F6-E1B0-4D42-9E8B-F83336AD99DFQ34977975-593213C7-FA25-46EB-A8C7-A05AD09A86E0Q35017752-1F35C1E3-B1E7-403D-A3A3-7A1AC71D65ECQ35153884-FA0C69E6-50D3-4366-979D-70B94CA008BAQ35156869-9A43FCAC-6AF1-4B87-91B6-914F265755A6Q35192906-9BB188CE-091F-47E8-A970-0AB83741DAC5Q35207704-93BE1AA2-22C4-4802-BEBA-7679442F41F1Q35233858-82D58F8E-3A28-42EB-AF96-4D2FAE75E828Q35294211-B4F8F8E4-CC16-460B-BA5A-F2FDFE7A66AFQ35662043-A15A1048-579E-4655-A958-BF10653AB3FAQ35679338-9AB689CB-1E94-4C90-9093-125F3AA112F9Q35717941-2032B098-4404-44E6-ABD0-E7E1A336C2CAQ36157238-85DC0383-D258-41B5-B599-E91E620DFBC5Q36171917-9A13839C-7169-4EB9-BB20-21C524F47C88Q36260387-3656A0B5-EA3F-46A9-B5EE-D1EEDBA215E8Q36324771-1526B918-3982-4E20-808B-84DAEDE5FAD7Q36339514-F6FB6B6D-06E0-43B8-BC09-301E5E7A2E7AQ36538936-C5A80B04-952D-4561-8A84-875DD4D094CCQ36629924-75BA3196-E5DC-42AA-8505-E5AAFAD488FDQ36788555-E9A544AF-838A-424C-855C-5AFC51FFBA51Q36865120-8C89E3A6-4AF4-4C3D-9F89-16188C5372AEQ36867626-DC3CBE87-68C2-4290-93BB-232009F93DDEQ37000498-14A84271-6D7A-4E47-9E24-994CA9BB9169Q37070084-665D81D0-AA73-488F-8522-4F9D2249912EQ37099741-AB3B2C4D-B89B-4FC3-B3D6-0BD78E756A4DQ37179502-298FADAA-8466-417F-96E6-5D588FBE0F18Q37245971-5C9FE14D-3557-47CB-A057-FDE20902D655Q37283355-1EF81381-B01C-494F-A0E8-C5D72A6F90A9Q37333523-6D9B84FA-AC12-4AC3-B715-FAB8A013E170Q37627860-ABB3D104-E84D-42B6-921A-BFE935AF1383Q37631043-B2916BAF-552B-4315-83B8-B64D07AF2CF8Q37656043-6C1CECC4-2641-423E-BF80-5E48B441F333Q38103913-C9F40231-33B8-4FC4-9030-C239ED96A755Q38663596-9312EFBD-AC23-43E8-A9E5-CFEFE20ADE8AQ38744738-C9C93D43-72B4-4BE6-B5EF-145494CF1A14Q38750362-A85F23EE-477F-40DF-A5FE-ECB093D0FD38
P2860
Identification of a novel inhibitor of the canonical Wnt pathway.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of a novel inhibitor of the canonical Wnt pathway.
@ast
Identification of a novel inhibitor of the canonical Wnt pathway.
@en
type
label
Identification of a novel inhibitor of the canonical Wnt pathway.
@ast
Identification of a novel inhibitor of the canonical Wnt pathway.
@en
prefLabel
Identification of a novel inhibitor of the canonical Wnt pathway.
@ast
Identification of a novel inhibitor of the canonical Wnt pathway.
@en
P2093
P2860
P356
P1476
Identification of a novel inhibitor of the canonical Wnt pathway.
@en
P2093
Anne R Murray
Guoquan Gao
Jian-Xing Ma
Kyoungmin Park
Kyungwon Lee
P2860
P304
P356
10.1128/MCB.01211-10
P407
P577
2011-05-16T00:00:00Z